Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
ACS Medicinal Chemistry Letters|May 31, 2021
Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and PsoriasisQingjie Liu, Hai-Yun Xiao, Douglas G Batt, et al.Journal of Medicinal Chemistry|February 14, 2014
Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvirMakonen Belema, Van N Nguyen, Carol Bachand, et al.Journal of Medicinal Chemistry|March 21, 2019
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)Scott H Watterson, Qingjie Liu, Myra Beaudoin Bertrand, et al.Journal of Medicinal Chemistry|September 2, 2016
Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked AtropisomersScott H Watterson, George V De Lucca, Qing Shi, et al.Journal of Medicinal Chemistry|October 23, 2019
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo EfficacyDavid Marcoux, James J-W Duan, Qing Shi, et al.Journal of Medicinal Chemistry|May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological DisordersQingjie Liu, Qing Shi, David Marcoux, et al.Journal of Medicinal Chemistry|February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Ying Wang, Wei Meng, et al.Pageof 5